I believe the MHRA just showed their hand approving two
I believe the MHRA just showed their hand approving two other MAB’s that failed their trials ans frankly aren’t half as SAFE as leronlimab. I think we have a great shot of hitting Pvalue for full approval but I believe Cytodyn will get EUA and I I actually think it will move as quickly as amarex can get the data to Cytodyn to be able
To apply for EUA. I think EUA is a lock based of risk benefit analysts that FDA head Steven Hahn has spoke of. I also think that EUA could
Have been granted months ago at 50% but it was important that company and DSMC recommended another look at 75% cytodyn decided that they liked there chances at full approval so much that that is what ultimate goal was and quickly filled the remaining 50% in order to get best Pvalue. If they do not hit pvalue im 99.99% sure EUA will be coming. Way to many arrows pointing to it, EIND’s reinstated, Than Open Label of cd-12 Approved with guidance, fda assist in making check list for drs/hospitals to make EIND’s more seamless. Medicare code being assigned specifically for Leronlimab. Couple months ago writing was painted on the wall I now Believe paint is dry and even easier to read. I have 3x my position since October. I has always though high floor and extremely high ceiling being invested in this company, ans funny thing is Nadar actually used my analogy that I use when I play fantasy sports. Some guys have a very low floor with high ceiling like a bench player, they could score 4 points one night and 26 the next. Or a guy who always scores 20+ points in a game but also has unbelievable nights a couple times a month where they score 56 points would be a high floor high ceiling fantasy player. This stock is like the Michael Jordan of stocks. Right now some are we’re disappointed that they feel they have Michael jordan and he’s scoring 25 points a night and getting no recognition for it kinda like CYDY now but when it’s playoff time more eyes on Michael to keep winning to make it to championship where all eyes on him, CYDY is in playoffs once unblocking happens we made the championship, ans mich like
Michael Jordan shines when the spotlight is on him in the championship CYDY will shine dropping one of those historic 63 point games to win the COVID-19 championship. Long story short Don’t bet against Michael Jordan and Don’t bet against CYDY. If you do your guaranteed a loss. It’s also easy decision put your money on the winner that’s been pricing itself since April all the other teams knocked out I guess we’re really just waiting for our championship rings. Good night GLTA
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...
Continue Reading
Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...
Continue Reading
Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...
Continue Reading
AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...
Continue Reading
America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...
Continue Reading
Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...
Continue Reading
When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...
Continue Reading
Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...
Continue Reading
Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...
Continue Reading
Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...
Continue Reading
Top 5 Most Recently Viewed Articles
Ecolab's Upcoming Quarterly Earnings Report Ecolab (ECL) is gearing up to announce its quarterly earnings report soon, creating anticipation among investors and analysts alike. This report will bring forth crucial data that could indicate the company's financial health and future outlook. Investors are keenly watching for any signs of growth or changes in direction....
Continue Reading
H&T Group Plc Trading Disclosure Overview As stakeholders in the financial markets, understanding the intricate details of trading disclosures is crucial. This article delves into the recent trading activities of H&T Group Plc, ensuring clarity on the transparency and accountability with which such dealings are conducted. Key Information About H&T Group Plc H&T Group Plc...
Continue Reading
Innovative Partnerships Enhance Wildfire Response Efforts Combined Next-gen technology could change how the world responds to wildfires Collaboration Brings Expertise to the Table In an exciting development, Valley Christian Schools (VCS) have made significant strides in the XPRIZE Wildfire competition by partnering with Kaizen Aerospace and SensoRy AI. This marks a...
Continue Reading
El Chato: The Culinary Jewel of Latin America El Chato, a celebrated establishment in Bogotá, has achieved the prestigious title of The Best Restaurant in Latin America for 2025, as sponsored by renowned partners. This marks a rise of two places from its previous ranking, solidifying its status as a leader in innovative cuisine. Celebrating Culinary Diversity The ranking...
Continue Reading
Strong Performance from Restaurant Brands International Restaurant Brands International Inc. (NYSE: QSR) has recently seen its shares rise following a stronger-than-expected performance in the third quarter. The company, known for its popular fast-food chains, reported impressive growth largely attributed to its flagship brand, Burger King, which outpaced industry...
Continue Reading